Yves Dudal, Ph.D

CEO at Perseo Pharma

Speaker

Bioengineer by training and with a PhD form Montreal Polytech, Dr. Yves Dudal has been heartedly engaged for the past 15 years in founding, funding, and growing 3 biotech startups in a scope ranging from ecodiagnostics, pharmaceutical biomanufacturing, and more recently, biopharmaceuticals development. Yves is currently the CEO of Perseo pharma, a Swiss preclinical stage startup company developing oral prophylactic drugs acting topically in the gut lumen for metabolic rare diseases. In his various ventures, and particularly at Perseo, Yves has experienced the great benefits of setting up early multiple partnerships with various stakeholders. He will discuss that today with us.